<sentence id="0">STAT3 activation has been implicated in the pathogenesis of RA .</sentence>
<sentence id="1">Active STAT3 is constitutively expressed in synovial fluid mononuclear cells from RA patients [ 36 ] .</sentence>
<sentence id="2">IL-6 is the major STAT3-activating factor present in synovial fluid , which has a crucial role in the activation of monocyte functions such as gene expression of the Fc gamma receptor type I and type III and of HLA-DR [ 31 ] .</sentence>
<sentence id="3">More recently , high levels of activated STAT3 , <scope type="spec" id="0"> <cue type="spec" id="0">thought</cue> to be induced mainly by IL-6</scope> , have been detected in the ST , and STAT3 activation has been shown to be involved in synovial fibroblast proliferation and IL-6 production [ 37 ] .</sentence>
<sentence id="4">In this regard , STAT3 is critical in the survival and expansion of growth factor-dependent synovial fibroblasts [ 38 ] .</sentence>
<sentence id="5">Furthermore , <scope type="spec" id="1"> the significance of persistent STAT3 signaling in Th1-cell-dominated autoimmune arthritis has been <cue type="spec" id="1">suggested</cue> by studies of the gp130F759/F759 mice , in which the Src homology phosphatase-2 binding site of gp130 ( the transmembrane glycoprotein beta subunit of the IL-6 family cytokine receptor ) , tyrosine 759</scope> , was mutated to phenylalanine [ 39 ] .</sentence>
<sentence id="6">In the gp130F759/F759 mice , T cells , particularly the CD4+ T-cell subset , are chronically activated and resistant to activation-induced cell death through gp130-mediated STAT3 activation .</sentence>
<sentence id="7">The longevity of cytokine signals transduced by the JAK-STAT pathway is regulated by the SOCS family proteins [ 7 ] .</sentence>
<sentence id="8">We found that CD4+ T cells from patients with active RA expressed higher levels of SOCS1 , but lower levels of SOCS3 , compared with normal CD4+ T cells .</sentence>
<sentence id="9">SOCS1 prevents activation of JAK by directly binding to JAK , and SOCS3 inhibits the action of JAK by binding to the Src homology phosphatase-2-binding domain of receptors such as gp130 [ 40 ] .</sentence>
<sentence id="10">SOCS1 and SOCS3 are induced by various cytokines , including IL-6 and IL-10 , as mediators of negative feedback and crosstalk inhibition [ 7 ] .</sentence>
<sentence id="11">Recent studies with mice <scope type="neg" id="2"><cue type="neg" id="2">lacking</cue> SOCS3 or SOCS1</scope> revealed that SOCS3 is a negative regulator of IL-6 signaling but <scope type="neg" id="3"><cue type="neg" id="3">not</cue> of IL-10 signaling</scope> .</sentence>
<sentence id="12">Studies of conditional SOCS3-deficient mice have shown that SOCS3 deficiency , but <scope type="neg" id="4"><cue type="neg" id="4">not</cue> SOCS1 deficiency</scope> , results in sustained activation of STAT3 in response to IL-6 [ 8,41 ] .</sentence>
<sentence id="13">The analysis of SOCS3-deficient macrophages has <scope type="spec" id="5"> <cue type="spec" id="5">indicated that</cue> SOCS3 is a crucial inhibitor of the IL-6-induced transcriptional response [ 42</scope> ] .</sentence>
<sentence id="14">However , SOCS3 is dispensable for both the negative feedback inhibition and the immunoregulatory action of IL-10 in macrophages [ 41 ] .</sentence>
<sentence id="15">On the contrary , SOCS1 was found to directly inhibit IL-10-mediated signaling [ 43 ] .</sentence>
<sentence id="16"><scope type="spec" id="6"> Increased SOCS1 expression in RA CD4+ T cells <cue type="spec" id="6">may</cue> therefore be associated with both the impaired responsiveness to IL-10 and to IL-10-mediated STAT3 activation</scope> , and defective SOCS3 expression <scope type="spec" id="7"> <cue type="spec" id="7">may</cue> be responsible for persistent STAT3 activation in response to serum IL-6</scope> .</sentence>
<sentence id="17">There is a <scope type="spec" id="8"> <cue type="spec" id="8">possibility</cue> that <scope type="spec" id="9"> SOCS1 induction <cue type="spec" id="9">may</cue> be associated with the ability of CD4+ T cells to produce IFN-gamma , because CD4+ T cells from active RA could produce high levels of IFN-gamma in the presence of IL-10 , and because IFN-gamma has been known as a potent inducer of SOCS1 [ 32</scope></scope> ] .</sentence>
<sentence id="18">It is of interest in this regard to <scope type="spec" id="10"> <cue type="spec" id="10">indicate that</cue> polarized Th1 and Th2 cells express high levels of SOCS1 and SOCS3 mRNA , respectively [ 44</scope> ] .</sentence>
<sentence id="19">IL-12-induced STAT4 activation is inhibited by SOCS3 induction in Th2 cells , whereas IL-4-induced STAT6 signaling is diminished by SOCS1 induction in Th1 cells .</sentence>
<sentence id="20">SOCS1 and SOCS3 <scope type="spec" id="11"> <cue type="spec" id="11">may</cue> thus have important roles as Th1-specific and Th2-specific , mutually exclusive , cross-talk repressors of the IL-4-STAT6 and the IL-12-STAT4 signaling pathways , respectively</scope> .</sentence>
<sentence id="21">Consistent with this <scope type="spec" id="12"> <cue type="spec" id="12">notion</cue> , PB T cells from patients with allergic diseases significantly express high levels of SOCS3 transcripts , and the SOCS3 expression correlates well with serum IgE levels and disease pathology [ 45 ]</scope> .</sentence>
<sentence id="22">Higher SOCS1 expression with lower SOCS3 expression in PB CD4+ T cells from RA patients , compared with healthy controls , is therefore <scope type="spec" id="13"> <cue type="spec" id="13">probably</cue> consistent with their systemic bias towards a Th1 phenotype</scope> , as has previously been demonstrated [ 46-49 ] .</sentence>